Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2010-10-28
pubmed:abstractText
Endothelial progenitor cells (EPC) are good candidates for cell-based therapy in cardiovascular diseases. However, concerns have been raised about the potential risks of EPC-based cell therapy, in terms of thrombogenicity particularly in inflammatory conditions, currently observed in such patients. Tissue factor (TF) can trigger coagulation and may support thrombogenicity. TF is also a key receptor in angiogenesis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1538-7836
pubmed:author
pubmed:copyrightInfo
© 2010 International Society on Thrombosis and Haemostasis.
pubmed:issnType
Electronic
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2042-52
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Tissue factor up-regulation in proinflammatory conditions confers thrombin generation capacity to endothelial colony-forming cells without influencing non-coagulant properties in vitro.
pubmed:affiliation
Laboratoire d'Hématologie, CHU Robert Debré and EA-3801, Faculté de Médecine, IFR-53 Interactions Cellules MicroEnvironnement, Université de Reims Champagne-Ardenne, Reims, France.
pubmed:publicationType
Journal Article